Oxford University Innovation spin-out Genomics raises £10.3m

27th November 2014

Genomics, a 2014 spin-out developing an analytical platform for genomic sequence data analysis, has completed a £10.3 million fundraising.

The funding came from new investors, including funds managed by Invesco Perpetual, Lansdowne Partners, Woodford Investment Management and the Wylie Family Trust, as well as existing shareholders including IP Group, one of its managed funds, and the University of Oxford.

Genomics, whose founders include Professors Peter Donnelly and Gil McVean, has developed a unique analytical platform for genomic sequence data analysis and interpretation and has already been awarded two grants funded by the Department of Health and managed by Genomics England to develop its technology. The Company is also working with pharmaceutical companies to bring the benefits of genomic analysis to the drug development process.

Further detail is available from investor IP Group’s press release.

Press release sign up